Notably, no CRC cell line with co-occurring KRAS and BRAF mutations was found and included in the present study, according to previous reports showing a pattern of mutual exclusivity for KRAS and BRAF mutation in human CRC [14]. The gene discussed is KRAS; the disease is colorectal carcinoma.